Atlas Trials

Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)

Clinical trial NCT07155200 · RECRUITING

Trial details

NCT number
NCT07155200
Sponsor
Washington University School of Medicine
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Small-cell Lung CancerSmall Cell Lung CarcinomaSmall Cell Lung Cancer
Start date
2025-12-18
Primary completion
2028-07-31
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.